Microbial adhesion and pathogenesis result in serious problems in world.
Introduction
Food spoilage due to microbial adhesion is a great problem. Due to food spoilage there is not only a nutritional loss but also an economical loss [1]. Chemical preservatives are not appropriate due to their hazardous effects on human health. It is very important to resolve this problem to fulfill the food requirement of rising world. In this era, natural and microbiological methods are being used to preserve the food [2]. To manage the economic loss, use of bacteriocins as preservative in the food industries is a satisfactory approach. In the recent world, bacteriocins application are gaining interest as they are generally regarded as safe (GRAS) which has a rich α-helix confirmation. Bacteriocin was purified through HPLC (high performance liquid chromatography) and ion exchange chromatography and when it tested against food borne pathogen showed minimum inhibitory concentration MIC value of 0.3-38.4 μg/ml. Moreover, it was noted that BMP11 had a bactericidal mode of action. Transmission electron microscope and scanning electron microscope (SEM) results showed that BMP11 destroyed the pathogen cell envelop integrity with cell membrane permeability ad cell wall perforation.
Cells envelop integrity destruction further identified through lactic dehydrogenase release and propidium (PI) uptake. Meanwhile, in milk it inhibits the growth of Listeria monocytogen and exhibits the antibiofilm formation activity. Therefore, BMP11 has a potential to act as antimicrobial and used as preservative to control the foodborne pathogen in dairy product GLc05 and GLc03) were tested for cytotoxicity in Vero cells (50% Cytotoxicity Concentration: CC50), and for their antiviral activities against Poliovirus (PV-1) and Herpes simplex virus 1 (HVS-1) strains. Semi-purified bacteriocins presented low cytotoxicity, with CC50 varying from 256.2 μg/mL (GLc05) to 1,084.5 μg/mL (GEn14) [96]. CC10 were determined for all isolates (GLc03: 36.9 μg/mL; GLc05: 51.2 μg/mL; GEn09: 88.1 μg/mL; GEn12: 99.9 μg/mL; GEn14: 275 μg/mL; GEn17: 62.2 μg/mL) and considered for antiviral activity assays. Antiviral activity before virus adsorption was noted against HSV-1 for GEn14 (58.7%), GEn12 (27.9%), and GEn17 (39.2%) and against PV-1 for GLc05 (4.9%), GEn09 (3.4%), GEn12 (24.7%) and GEn17 (23.5%). Antiviral activity after virus adsorption was identified against HSV-1 for GEn17 (71.6%) and against PV-1 for GLc05 (32.7%), GEn09 (91.0%), GEn12 (93.7%) and GEn17 (57.2% 
Conclusion
Bacteriocins are the antimicrobial peptides synthesized by bacteria for their survival. These extracellular peptides are very beneficial on industrial scale. They exhibit the ability to inhibit the wide variety of microorganisms. They not only inhibit the growth of closely related bacteria but also have ability to inhibit the growth of viruses and fungus. The ability of bacteria to produce bacteriocin which have inhibitory spectrum might be used for the welfare of human beings and their efficacy in pharmaceutical industries might be exploited by enhancing its production by bacteriocin engineering. However, shifting the antimicrobial spectrum increases potency and stabilization is still a challenging field. Computational approaches to revolutionize the bacteriocin potency through chemical and biological modification are also on way, but more research is needed to explore the behavior and utility of bacteriocin on commercial scale. 
